A nonprofit publication of the Kentucky Center for Public Service Journalism

Trudy Lieberman: Rising drug prices put pressure on Congress, but drug makers remain a powerful lobby

Maybe – just maybe – Americans will get some relief from the relentlessly rising prices of pharmaceuticals. That, of course, depends on Congress pushing back against the drug companies’ formidable lobbying machine, their generous campaign contributions, and the industry’s historical coziness with members of Congress. But this year seems different. When you consider that the country’s spending...